Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment

Lignende værker

• Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab
  af: Ornetti, P, et al.
  Udgivet: (2005)
• Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate
  af: Keystone, Edward C, et al.
  Udgivet: (2015)
• Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
  af: Schiff, M, et al.
  Udgivet: (2008)
• Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial
  af: Kremer, Joel M, et al.
  Udgivet: (2011)
• Abatacept in the treatment of rheumatoid arthritis
  af: Vital, Edward M, et al.
  Udgivet: (2006)